Tag: drug safety issue
-
Ukoniq FDA Advisory Committee Meeting in April 2022 Will Evaluate Ukoniq Drug Safety Findings
FDA Has Been Investigating Ukoniq for an Increased Risk of Death in Lymphoma Cancer Patients Treated With Ukoniq (Posted by Tom Lamb at Drug Injury Watch) UPDATE: Ukoniq Drug Recall in April 2022 Comes Soon After…
-
Two Padcev SJS / TEN Case Reports Published Before March 2021 Padcev Label Change About These Skin Reactions
When Astellas Pharma First Knew About SJS / TEN Side Effects Is A Key Fact In This Still Developing Padcev Drug Safety Issue (Posted by Tom Lamb at Drug Injury Watch) About a month ago,…
-
Acute Pancreatitis Case Associated With Victoza Use, Similar To Byetta And Januvia Case Reports
Drug Safety Issue Controversy Continues: True Serious Side Effect, Or Attributable To Type 2 Diabetes Condition (Posted by Tom Lamb at DrugInjuryWatch.com) ______________________________________________________________________________ UPDATE: Victoza (liraglutide [rDNA origin]) Injection: REMS – Risk of Thyroid…